These authors contributed equally to this work.
1349-7006/asset/cas_centre.gif?v=1&s=11108c6693d2a39ca49ee937260cc26f94293b0d)
1349-7006/asset/cas_right.gif?v=1&s=8b26cd26c2b4c8264011a9ddc0ed1cf4aaee0b20)
Original Article
You have free access to this content
Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progression
Article first published online: 3 APR 2012
DOI: 10.1111/j.1349-7006.2012.02252.x
© 2012 Japanese Cancer Association
Additional Information
How to Cite
Yuen, H.-F., McCrudden, C. M., Grills, C., Zhang, S.-D., Huang, Y.-H., Chan, K.-K., Chan, Y.-P., Wong, M. L.-Y., Law, S., Srivastava, G., Fennell, D. A., Dickson, G., El-Tanani, M. and Chan, K.-W. (2012), Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progression. Cancer Science, 103: 1145–1154. doi: 10.1111/j.1349-7006.2012.02252.x
- †
These authors contributed equally to this work.
Publication History
- Issue published online: 1 JUN 2012
- Article first published online: 3 APR 2012
- Accepted manuscript online: 26 FEB 2012 11:37PM EST
- Manuscript Accepted: 20 FEB 2012
- Manuscript Revised: 17 FEB 2012
- Manuscript Received: 28 SEP 2011
References
- 1
- 2, , . Epidemiology of esophageal cancer: orient to occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 2009; 24: 729–35.
- 3, , et al. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 2004; 22: 900–8.
- 4, , et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet 2010; 42: 759–63.
- 5, , et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention. Int J Clin Oncol 2010; 15: 126–34.
- 6, , et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet 2010; 42: 764–7.
- 7. BMP antagonists: their roles in development and involvement in pathophysiology. Cytokine Growth Factor Rev 2005; 16: 309–17.
- 8, , et al. Bone morphogenetic protein expression patterns in human esophageal atresia with tracheoesophageal fistula. Pediatr Surg Int 2006; 22: 154–7.
- 9, , , , . Morphogenesis of the trachea and esophagus: current players and new roles for noggin and Bmps. Differentiation 2006; 74: 422–37.
- 10, , , . Aberrant Bmp signaling and notochord delamination in the pathogenesis of esophageal atresia. Dev Dyn 2007; 236: 746–54.
- 11, , et al. Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells. Gastroenterology 2007; 132: 2412–21.
- 12, , et al. FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis. Gut 2009; 58: 166–73.
- 13, . The molecular pathogenesis of Barrett's esophagus: common signaling pathways in embryogenesis metaplasia and neoplasia. J Gastrointest Surg 2010; 14(Suppl. 1): S81–7.
- 14, , , , , . Expression, regulation and clinical significance of bone morphogenetic protein 6 in esophageal squamous-cell carcinoma. Int J Cancer 1999; 83: 38–44.
- 15, , , , , . The prognostic significance of BMP-6 signaling in prostate cancer. Mod Pathol 2008; 21: 1436–43.
- 16, , , , . BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype. J Pathol 2008; 214: 394–404.
- 17, , et al. Immunolocalization and mRNA expression of bone morphogenetic protein-6 in human clear cell renal carcinoma. Kidney Blood Press Res 2009; 32: 445–50.
- 18, , , , . The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter. J Clin Pathol 2002; 55: 381–5.
- 19, , et al. A novel osteogenic helioxanthin-derivative acts in a BMP-dependent manner. Biochem Biophys Res Commun 2007; 357: 854–60.
- 20, , et al. Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells. Circulation 2002; 106: 2263–70.
- 21, , , , . Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol Cell Biol 2004; 24: 4241–54.
- 22, , et al. Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma. Br J Cancer 2007; 97: 1409–15.
- 23, , et al. Differential regulation of steroidogenesis by bone morphogenetic proteins in granulosa cells: involvement of extracellularly regulated kinase signaling and oocyte actions in follicle-stimulating hormone-induced estrogen production. Endocrinology 2007; 148: 337–45.
- 24, , et al. BMP-6 inhibits human bone marrow B lymphopoiesis–Upregulation of Id1 and Id3. Exp Hematol 2006; 34: 72–81.
- 25, , et al. Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood 2008; 112: 1503–9.
- 26, , et al. Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis. Gastroenterology 2009; 137: 1489–97.
- 27, , et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010; 18: 11–22.
- 28, , et al. Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors. J Clin Oncol 2010; 28: 2660–7.
- 29, , et al. Metastasis-associated gene expression changes predict poor outcomes in patients with dukes stage B and C colorectal cancer. Clin Cancer Res 2009; 15: 7642–51.
- 30, , et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 2010; 138: 958–68.
- 31, , , . PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genomics 2009; 2: 18.
- 32, , et al. Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through snail-induced epithelial-mesenchymal transition. J Pathol 2011; 224: 78–89.
- 33, , , , . Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts. Bone 2004; 35: 448–54.
- 34, , . Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. J Clin Invest 1998; 102: 2106–14.
- 35, , et al. Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity. J Biol Chem 2003; 278: 24113–7.
- 36, , , , , . Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism. Cancer Res 2005; 65: 8274–85.
- 37, . Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis? Endocr Relat Cancer 2010; 17: R123–39.
- 38, , , , , . Bone morphogenetic proteins and cancer: review of the literature. Neurosurgery 2010; 66: 233–46; discussion 46.
- 39, , , . Bone morphogenetic protein signalling in colorectal cancer. Nat Rev Cancer 2008; 8: 806–12.
- 40, , et al. First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer. J Pathol 2005; 206: 366–76.
- 41, . The disparate role of BMP in stem cell biology. Oncogene 2005; 24: 5713–21.
- 42, , , . BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 2003; 115: 281–92.
- 43, , , , . Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC. Clin Cancer Res 2001; 7: 2213–21.
- 44, , et al. Id-1 activation of PI3K/Akt/NFkappaB signaling pathway and its significance in promoting survival of esophageal cancer cells. Carcinogenesis 2007; 28: 2313–20.
- 45, , et al. Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease. Clin Chim Acta 2010; 411: 1452–6.